Why the study?
Do digital biomarkers from wearable and chatbot monitoring improve the prediction of adverse cardiac events compared to SMART2 risk score and lifestyle questionnaires in patients with established coronary artery disease after revascularization?
Population
66 patients with coronary artery disease recovering from coronary revascularisation
Comparison
Digital biomarkers from wearable and chatbot… vs SMART2 risk score clinical parameters and…
Design
Cohort
Follow-up
two years
Authors
Loading...
Should not yet change post-revascularization care; leaves open whether wearable and chatbot data enhance adverse event prediction.
Do digital biomarkers from wearable and chatbot monitoring improve the prediction of adverse cardiac events compared to SMART2 risk score and lifestyle questionnaires in patients with established coronary artery disease after revascularization?
Early post-discharge digital monitoring of sleep, activity, and circadian HR dynamics predicts adverse cardiac events more accurately than standard clinical risk scores in patients recovering from coronary revascularization.
Blerck et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: